METHOD FOR DETECTING AUTOANTIBODIES
A method for the detection of autoantibodies comprises detecting autoantibodies in a sample from an individual using label free electrochemical impedance spectroscopy. In one aspect, the method is a method for the diagnosis or monitoring of Parkinson's disease comprising detecting α-synuclein autoantibodies in a sample from an individual using electrochemical impedance spectroscopy. We also describe electrodes for use in these methods.
1 .- 16 . (canceled)
17 . A method for detection of autoantibodies, comprising detecting autoantibodies in a sample from an individual by label free electrochemical impedance spectroscopy.
18 . A method for diagnosis or monitoring of Parkinson's disease, comprising detecting α-synuclein autoantibodies in a sample from an individual by electrochemical impedance spectroscopy.
19 . The method according to claim 18 , wherein the method comprises contacting (i) an electrode having α-synuclein or an antibody binding fragment thereof attached to a surface thereof, with (ii) the sample; and detecting an electrical signal associated with binding of α-synuclein antibody to the α-synuclein or antibody fragment binding fragment thereof.
20 . The method according to claim 19 , wherein the method further comprises adding a redox probe to the sample; and detecting a second electrical signal by Faradaic electrochemical impedance spectroscopy.
21 . The method according to claim 18 , wherein the sample comprises a biological fluid selected from blood, urine and cerebral spinal fluid.
22 . The method according to claim 21 , wherein the sample is a blood serum sample.
23 . The method according to claim 21 , wherein the method is conducted on an undiluted biological sample.
24 . The method according to claim 18 , wherein α-synuclein autoantibodies in the sample are detected as antibodies bound to an electrochemical impedance spectroscopy electrode, and wherein the method is conducted in an absence of any label for the bound antibodies.
25 . The method according to claim 21 , wherein the method comprises contacting an electrochemical impedance spectroscopy electrode with the sample to allow α-synuclein antibodies in the sample to bind to the electrode, rinsing the electrode to remove unbound species, and detecting an electrical signal in the presence of a redox probe.
26 . The method according to claim 18 , wherein the method comprises calculating a concentration of α-synuclein antibodies from an electrochemical impedance spectroscopy electrical signal.
27 . The method according to claim 18 , wherein an electrochemical impedance spectroscopy electrical signal detected in the sample from the individual, or an α-synuclein antibody concentration calculated therefrom, is compared to a second electrochemical impedance spectroscopy electrical signal that is obtained from a second sample from an individual not suffering from Parkinson's disease or to a second α-synuclein antibody concentration calculated therefrom.
28 . The method according to claim 18 , wherein the method is conducted on samples taken from the same individual over a period of time in order to monitor progression of Parkinson's disease in the individual.
29 . The method according to claim 19 which further comprises at least one of: (a) dissociating α-synuclein antibodies from the α-synuclein or antibody binding fragment thereof attached to the electrode, and (b) reusing the electrode in one or more further methods for detecting α-synuclein antibodies in an electrochemical impedance spectroscopy technique.
30 . An electrode for use in electrochemical impedance spectroscopy, comprising:
(a) a substrate having a planar surface; and
(b) α-synuclein or an antibody binding fragment thereof disposed on the planar surface.
31 . The electrode according to claim 30 , wherein said substrate is a gold substrate.
32 . The electrode according to claim 30 , wherein said substrate is coated with polyethylene glycol thiol for binding to the α-synuclein or antibody binding fragment thereof.